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Bacterial biofilms in the colon alter the host tissue
microenvironment. A role for biofilms in colon can-
cer metabolism has been suggested but to date
has not been evaluated. Using metabolomics, we
investigated the metabolic influence that microbial
biofilms have on colon tissues and the related
occurrence of cancer. Patient-matched colon can-
cers and histologically normal tissues, with or
without biofilms, were examined. We show the upre-
gulation of polyamine metabolites in tissues from
cancer hosts with significant enhancement of N1,
N12-diacetylspermine in both biofilm-positive cancer
and normal tissues. Antibiotic treatment, which
cleared biofilms, decreased N1, N12-diacetylsper-
mine levels to those seen in biofilm-negative tissues,
indicating that host cancer and bacterial biofilm
structures contribute to the polyamine metabolite
pool. These results show that colonic mucosal bio-
films alter the cancer metabolome to produce a
regulator of cellular proliferation and colon cancer
growth potentially affecting cancer development
and progression.
INTRODUCTION
Colon cancer has numerous risk factors (Botteri et al., 2008;
Gay et al., 2012; Moskal et al., 2007), but recent studies high-
light a potential role for the colon microbiota in colon cancer
development (Sears and Garrett, 2014). The colon microbiota
can form structures, termed biofilms, that line the mucosal sur-Cface and indicate disruption of the normal colon mucous bar-
rier (Probert and Gibson, 2002; Shah and Swiatlo, 2008); in
addition, biofilms have been associated with non-malignant
pathologies such as inflammatory bowel disease (Swidsinski
et al., 2005). We have recently demonstrated that biofilms
are associated with human colon cancer and linked to cancer
location, with virtually all right-sided colon adenomas and
cancers possessing biofilms, while left-sided cancers are
infrequently biofilm positive (Dejea et al., 2014). Importantly,
histologically normal colon mucosa, collected from the surgi-
cal resection margin, was also biofilm positive or negative,
demonstrating 100% concordance with their paired cancer.
While differences in clinical prognosis and genetic characteris-
tics between right- and left-sided colon cancers have been
documented (Benedix et al., 2010; Meguid et al., 2008), the
role of specific microbes in different regions of the colon has
not yet been investigated. We thus hypothesized that biofilm
structure might affect cancer biology by modulating the me-
tabolome, yielding metabolites that enhance cancer growth.
We approached our hypothesis by investigating the colon
tissue metabolome using four independent metabolomic plat-
forms, permitting the examination of: (1) metabolic changes in
cancer tissues with and without biofilms, (2) the spatial
organization of metabolite distributions, and (3) the unbiased
assimilation of stable isotope-labeled metabolites into meta-
bolic pathways. Global (untargeted) and targeted analyses
were performed with liquid chromatography quadrupole
time-of-flight mass spectrometry (LC-QTOF-MS) and liquid
chromatography triple quadrupole mass spectrometry (LC-
QqQ-MS), respectively, whereas nanostructure imaging mass
spectrometry (NIMS) was utilized to identify the spatial distri-
bution of metabolites. Ultimately, we determined the metabolic
changes that biofilms have on colon tissue, the origin of the
metabolites, and their potential biological roles in the host
and microbiota.ell Metabolism 21, 891–897, June 2, 2015 ª2015 Elsevier Inc. 891
Figure 1. Untargeted Metabolomics
(A) Cloud plot showing dysregulated features between normal tissues and
patient-matched colon cancer tissues (n = 30, two-tailed Wilcoxon test). Total
ion chromatograms for each sample can be seen on the plot.
(B) Relative abundance of N1, N12-diacetylspermine (two-tailed Wilcoxon test,
****p < 0.0001). Error bars are SEM.
(C) Comparison of biofilm-negative cancers, n = 11 to biofilm-positive cancers
n = 8 (two-tailed Mann-Whitney test).
(D) Relative abundance ofN1,N12-diacetylspermine (two-tailedMann-Whitney
test **p < 0.01). Tandem MS spectrum of N1, N12-diacetylspermine in sam-
ples and standards is shown. Error bars are SEM. See also Table S1 and
Figure S1.RESULTS
UntargetedMetabolomics Reveals Increased Polyamine
Metabolites in Colon Cancers
Two patient groups of samples were obtained from Johns Hop-
kins University (JHU) School of Medicine and Karolinska Univer-
sity Hospital. Using an untargeted metabolomics analysis, 304
differentially regulated features were observed (JHU samples)
(Figure 1A) when comparing the colon cancer tissues to their
paired normal tissues (n = 30 patients). The feature with one of
the largest fold changes of 9.4-fold (p = 3.7e9, m/z = 287.240)
was identified as N1, N12-diacetylspermine (Figure 1B). Other
polyamine metabolites were also upregulated in the colon can-
cer tissue samples 3.7-fold (N1-acetylspermidine; m/z =
188.172, p = 1.9e8) and 3.6-fold (N1-acetylspermine; m/z =
245.235, p = 3.5e8). Further analysis revealed that a number
of features could be classified as phospholipids and fatty acids
(Table S1). Analysis of the Karolinska University Hospital sam-
ples (n = 30 patients) validated the upregulation of N1, N12-diac-
etylspermine 8.1-fold (p = 2.9e3), N1-acetylspermidine (p =
5.6e4, 3.2-fold), and N1-acetylspermine (p = 4.6e3, 2.2-fold).892 Cell Metabolism 21, 891–897, June 2, 2015 ª2015 Elsevier Inc.Many of the other metabolites seen in the JHU samples (phos-
pholipids, carnitines, fatty acids, and hypoxanthine) could not
be observed in this sample set (Table S1). These metabolites
have previously been identified with many other diseases as
well as colon cancer and have low specificity to just one disease
(Gonza´lez-Domı´nguez et al., 2014; Sampey et al., 2012). How-
ever, the observation of increased polyamine metabolites in
colon cancer tissues from both patient populations shows the
potential specificity of these metabolites, which are further
validated here. The presence of the acetylated polyamines,
phospholipids, and fatty acids suggests the involvement of
acetyl-CoA and upregulation of fatty acid oxidation. However,
untargeted analysis by hydrophilic interaction liquid chromatog-
raphy (HILIC) in positive and negativemode showed no presence
of acetyl-CoA or malonyl-CoA or further metabolic dysregulation
in the colon tissues.
Stratification by Biofilm Status Reveals an Upregulation
of N1, N12-Diacetylspermine
We next stratified our untargeted metabolomic analysis to deter-
mine if colon tissues with biofilms differed in their metabolic
features from those colon tissues lacking biofilms. Only 28
dysregulated metabolites were seen (Figure 1C). In the biofilm-
positive cancer tissues, the upregulation ofN1,N12-diacetylsper-
mine 3.8-fold (p = 2.5e3) (Figure 1D), N1-acetylspermidine (p =
4.1e2, 1.7-fold), and N1-acetylspermine (p = 2.0e2, 2.0-fold)
was observed. Of note, our sample set contained two biofilm-
positive cancer samples located on the left side of the colon,
which had the highest concentration ofN1,N12-diacetylspermine
out of all the cancer samples examined, suggesting that this
metabolite is not simply upregulated based upon location of
the cancer in the colon but rather specifically related to the pres-
ence of biofilm. The other metabolites that were significantly
changed included undecanoic acid, dodecanoic acid, capryloyl-
glycine, and isobutrylcarnitine.
Biofilm-positive cancer tissues were then compared to their
paired normal tissues and revealed an upregulation ofN1,N12-di-
acetylspermine 62.2-fold (p = 1.6e2), N1-acetylspermidine (p =
1.6e2, 6.5-fold), N1-acetylspermine (p = 1.6e2, 5.8-fold), and
spermidine (p = 2.7e2, 2.3-fold) in the cancer tissues (Fig-
ure S1A). Biofilm-negative paired colon cancer and normal
tissues were also compared and showed that N1, N12-diacetyl-
spermine, N1-acetylspermidine, N1-acetylspermine, and sper-
midine were upregulated 7.2-fold (p = 2.0e3), 3.0-fold (p =
2.9e3), 3.1-fold (p = 1.2e3), and 1.4-fold (p = 1.3e2),
respectively, in cancer tissues (Figure S1B). These results
demonstrate upregulation of acetylated polyamine production
within colon cancer tissues that is further enhanced in biofilm-
positive colon cancer tissues, most markedly for N1, N12-
diacetylspermine.
Targeted Validation Confirms Polyamine Metabolite
Changes
The polyamine metabolites were analyzed by QqQ-MS selected
reaction monitoring (Figure 2A), which confirmed that these
metabolites were significantly upregulated in cancer tissues,
regardless of biofilm status, compared to their paired normal
colon tissues (Figures S2A and S2B). Comparison of biofilm-
negative to biofilm-positive cancer tissues revealed significant
Figure 2. Biofilm Effects on Metabolites in Colon Tissues
(A) Scheme of polyamine metabolism. PAO, polyamine oxidase; SSAT, spermidine/spermine N1-acetyltransferase; ODC, ornithine decarboxylase; HAT, histone
acetyltransferase; SRM, spermidine synthase; SMO, spermine oxidase; SMS, spermine synthase).
(B) Targeted metabolomics, concentrations of metabolites in cancers with (n = 9) or without (n = 10) biofilms (two-tailed Mann-Whitney test). Empty symbols
indicate left-sided biofilm-positive samples. Error bars are SEM, *p < 0.05, n.s. = not significant.
(C) Nanostructure imaging mass spectrometry on biofilm-positive normal and cancer tissue. Scale = 100 mm.
(D) Hematoxylin and eosin staining, *mucosal edge. Scale = 500 mm left, 200 mm right column. See also Figure S2.upregulation of N1, N12-diacetylspermine only in the biofilm-
positive tissues (p = 1.8e2) (Figure 2B). Importantly, the
normal tissues, which were concordantly biofilm-negative
or -positive with their paired cancer tissues, revealed an
upregulation of N1, N12-diacetylspermine and N1-acetylsper-
mine (p = 2.3e2 and p = 4.1e2, respectively) in the biofilm-
positive normal colon tissues compared to biofilm-negative
normal colon tissues obtained from colon cancer hosts
(Figure S2C).
In Situ Imaging Reveals Metabolite Spatial Specificity
To further validate the LC/MS experiments and explore spatial
specificity within and between the normal and cancer tissues,
we usedNIMS (Northen et al., 2007). Figures 2C and 2D correlate
normal and cancer tissues with polyamine metabolite levels,
providing evidence that polyamine metabolite concentrations
(relative intensity) are higher in the cancer than in normal tissue
in situ. The enhanced detection of the acetylated metabolites
at the mucosal edge of the cancer tissue further suggested
that the microbial biofilm could be contributing to the signal de-
tected by NIMS.CN1, N12-Diacetylspermine Is Potentially Acetylated by
Bacterial Enzymes and Is an End-Product of Polyamine
Metabolism
Increased acetylated polyamine metabolite synthesis may origi-
nate from the host tissue and indicate cellular proliferation; Ki67
staining showed a significant increase in crypt epithelial cell pro-
liferation in normal tissues that were biofilm-positive compared
to biofilm-negative (Dejea et al., 2014). Increases in acetylated
polyamine metabolites could also arise from increased spermi-
dine/spermine N1-acetyltransferase (SSAT) expression; an in-
crease in SSAT could occur as a stress response to bacterial
infection and biofilm formation (Gerner et al., 1993). In the human
host, SSAT is required for acetylation of spermine to generate
N1, N12-diacetylspermine; thus, mucosal SSAT expression was
examined by immunohistochemical (IHC) staining and quantifi-
cation (Figure 3). No significant difference was detected in
epithelial cell SSAT between tissues with and without a biofilm
(Figure 3B), indicating that the upregulation in biofilm-covered
tissues is not due to increased mucosal SSAT acetylation of
polyamines by the host. Indeed, as polyamine metabolism is
universal among bacterial species and essential for bacterialell Metabolism 21, 891–897, June 2, 2015 ª2015 Elsevier Inc. 893
Figure 3. Immunohistochemical Analysis of
Spermidine/Spermine N1-Acetyltransferase
(A) SSAT IHC of cancer and paired normal tissues
from patients with and without a biofilm (scale
bar 50 mm).
(B) Scoring of epithelial SSAT IHC in cancers and
paired normal tissues with (n = 9) and without
(n = 11) a biofilm. Error bars are mean with SD.
n.s. = not significant
(C) HCT116 cells stimulated with N1, N11-bis(ethyl)
norspermine with positive SSAT staining com-
pared with unstimulated HCT116 cells lacking
SSAT.
(D) SSAT staining of cancer tissue with and without
primary antibody.
(E) IHC 0–3 scoring system with representative
cytoplasmic staining intensities. Selected inserts
are displayed in the bottom panel. All images were
captured at 4003 (scale bars 50 mm).survival, alternative bacterial SSAT acetyltransferases may
contribute (e.g., Bacillus subtilis [Woolridge et al., 1999]), and
we hypothesize that polyamine metabolites may be coopera-
tively produced by biofilm bacterial communities.
To further ascertain the biological effects of N1, N12-diacetyl-
spermine, colon cancer cell lines (HT-29) were dosed with
[U-14N]- and [U-15N]-N1, N12-diacetylspermine to assess its
metabolic fate by global isotope metabolomics. We observed
no reversible conversion of N1, N12-diacetylspermine to its pre-
cursors. Instead we observed the [U-14N]- N1, N12-diacetylsper-
mine and [U-15N]-N1,N12-diacetylspermine ions still present and
unconverted in the cells 24 hr after dosing. This shows that the
labeled metabolites entered the cells, but were not further
metabolized, and are most likely a metabolic end product.
Correlations between N1, N12-Diacetylspermine and
Taxonomic Composition Were Observed
The correlation between the taxonomic composition of bio-
film-positive samples and acetylated polyamines was also894 Cell Metabolism 21, 891–897, June 2, 2015 ª2015 Elsevier Inc.investigated. A positive association with
some Clostridia groups was seen,
including Sporobacter (r = 0.754, p =
0.0018), Peptostreptococcaceae (r =
0.691, p = 0.0062), and Veillonellaceae
(r = 0.668, p = 0.0091), indicating a
possible contribution to N1, N12-diace-
tylspermine production in biofilm-posi-
tive tumors. A negative association
was seen with the order Bacteroidales
from the Bacteroidetes class (r =
0.733, p = 0.0028).
Antibiotic Treatment Removed
Biofilms and Decreased N1, N12-
Diacetylspermine Levels
To further delineate the microbial versus
host source of the upregulated polyamine
metabolites identified, we collected tis-
sues from nine colon cancer patientstreated with oral antibiotics 24 hr prior to surgery. FISH analyses
of both right and left colon tissues from these antibiotic-
treated patients revealed no biofilms (Figure 4A), and microbial
culture revealed little to no anaerobic or aerobic microbial
growth on nutrient-rich agar, suggesting that oral antibiotic
treatment is effective at lowering the cultivatable microbial
load (Figure 4B). In the context of the finding that essen-
tially all right-sided cancers display biofilms while 88% of
left-sided cancers are biofilm-negative, the right and left
cancer samples were compared to each other, revealing
no significantly increased metabolites (Figure S3A). However,
comparison of all antibiotic-treated cancers to their paired
normal tissue by targeted metabolomics revealed an in-
crease in N1-acetylspermine (p = 1.6e2), N1-acetylspermidine
(p = 1.6e2), and N1, N12-diacetylspermine (p = 1.6e2) in
the cancer tissue (Figure S3B). A further comparison of
antibiotic-treated right-sided cancers to all biofilm-positive
cancers (from patients not receiving oral antibiotics prior to
surgery) revealed significantly less N1, N12-diacetylspermine
Figure 4. Antibiotic-Treated Cancers
(A) Fluorescent in situ hybridization of all bacteria
(red). Right-sided normal and paired cancer tissue
from non-antibiotic and antibiotic-treated patients,
DAPI counterstain (scale 10 mm).
(B) Microbial culture data from antibiotic-treated
(n = 8) (blue) and non-antibiotic-treated patients
(n = 8) (red). Absolute concentrations of metabo-
lites in (C) right-sided cancers from antibiotic-
treated patients (n = 6) and cancers with biofilms
(n = 9) from non-antibiotic-treated patients.
(D) Right-sided cancers from antibiotic-treated
patients (n = 6) and cancers without biofilms (n =
10) from non-antibiotic-treated patients. Statistics:
two-tailed Mann-Whitney test, error bars are SEM,
*p < 0.05, ***p < 0.001, ****p < 0.0001, n.s. = not
significant. See also Figure S3.(p = 3.3e2) in the antibiotic-treated right-sided cancers (Fig-
ure 4C). Moreover, antibiotic-treated right-sided cancers and
biofilm-negative cancer tissues from patients not treated
with oral antibiotics prior to surgery (Figure 4D) were metabol-
ically similar. Collectively, the data are consistent with the
interpretation that both host cells and microbial biofilms
contribute to upregulation of polyamine metabolites in colon
cancer.
Assessment of Colonoscopy Control Tissues Revealed
No Acetylated Polyamines
To test the specificity of the polyamine metabolite changes
to the cancer host and the acetylated metabolites to biofilm-
positive tissues, we examined biofilm-negative biopsies from
ascending (right) and descending (left) colon undergoing
routine screening colonoscopy. No acetylated polyamines
were observed by targeted metabolomics in the left- and
right-sided normal colonoscopy biopsies from healthy individ-
uals (Figure S3C). A comparison of the normal colon biopsies
to biofilm-positive normal tissues revealed upregulation of
spermine and N1-acetylspermidine in cancer host tissues (p =
5.0e2, p = 7.0e3) (Figure S3D). Spermine was also increased
in the biofilm-negative normal tissues from cancer hosts
compared to the normal colonoscopy biopsies from healthy in-
dividuals (p = 2.0e2) (Figure S3E). These results are consistent
with cellular metabolic changes occurring in histologically
normal colon tissues of the cancer-bearing host due to far-
reaching field effects covering a large proportion of the colon
(Dakubo et al., 2007).Cell Metabolism 21, 891–A Mouse Model of Bacterial-
Mediated Colon Tumorigenesis
Showed No Correlation between
Polyamine Metabolites and Tissues
In a relevant mouse model of bacteria-
mediated colon tumorigenesis and poly-
amine metabolism, colitis and distal colon
tumors that are biofilm-negative were
induced after enterotoxigenic Bacter-
oides fragilis (ETBF) colonization (Good-
win et al., 2011). We examined normal
and tumor tissues from these micethrough targetedmetabolomics and did not see a correlation be-
tween polyamine levels and tissues, supporting the observation
that polyamine levels are not perturbed in biofilm-negative
tissues.
DISCUSSION
The observation in this study is a direct correlation between bio-
film formation on colon cancers and the upregulation of N1, N12-
diacetylspermine, a polyamine metabolite that may affect the
growth of both cancer and its associated biofilm. Importantly,
although biofilms are nearly universal in association with right
colon cancers, the measurement of upregulated acetylated
polyamine metabolites on left biofilm-positive cancer and
paired normal tissues highlights that biofilm status, not merely
the colon region, drives the changes identified in polyamine
metabolism.
It is well known that themicrobiota and human tissues exhibit a
symbiotic relationship, and polyamines and their metabolites are
essential for both (Ridaura et al., 2013). Increased polyamine
concentrations are associated with eukaryotic proliferation
(Gerner and Meyskens, 2004), and microbiota require poly-
amines for growth, cell-wall synthesis, and biofilm formation
(Patel et al., 2006; Shah and Swiatlo, 2008). Biofilm formation,
even in the normal colon tissue, was associated with increased
colonic epithelial cell proliferation (Dejea et al., 2014) and
enhanced polyamine metabolism. Thus, our data indicate bio-
films increase polyamine metabolite concentrations in both
normal and cancer tissues. The increase of carnitines and fatty897, June 2, 2015 ª2015 Elsevier Inc. 895
acid metabolites in the colon cancer tissues suggests increased
inflammation. Indeed, an increase in both interleukin 6 (IL-6) and
signal transducer and activator of transcription 3 (Stat3) activa-
tion were seen in biofilm-positive compared to biofilm-negative
normal tissues from the cancer host (Dejea et al., 2014).
Although the molecular details remain to be identified, we
propose a model in which host and bacterial polyamine metab-
olites act synergistically to promote biofilm formation and
cellular proliferation, creating conditions conducive to onco-
genic transformation in colonic epithelial cells. Consistent
with this hypothesis, studies have shown that ornithine decar-
boxylase (ODC) and SSAT mRNA expression are affected by
microbiota in human cancer cell lines (Linsalata et al., 2010).
Helicobacter pylori, for example, can upregulate c-MYC, acti-
vating ODC (Bussie`re et al., 2005). However, here, SSAT was
not increased in host normal or cancer mucosa when biofilms
were present, indicating that N1, N12-diacetylspermine is pro-
duced in biofilm-positive tissues through bacterial acetylation.
Therefore, changes in host cell metabolism may provide poly-
amines to stimulate biofilm formation in colon mucosa. Indeed,
bacterial transporters for uptake of extracellular polyamines
exist (Patel et al., 2006). Collectively, the upregulation of poly-
amine metabolism can enhance cancer growth, invasion, and
metastasis (Soda, 2011). Although ideal for further mechanistic
studies, a murine model of biofilm-positive proximal colon tu-
mors is not available and unlikely to emerge given the reported
differences in mucus: bacterial interactions between murine
and human hosts (Johansson and Hansson, 2011; Swidsinski
et al., 2009).
Treatment of colon cancer models and clinical trials with
polyamine-metabolism inhibitors have resulted in ambiguous
findings (Babbar and Gerner, 2011); however, targeting both
polyamine production and biofilm interactions could prove to
be a more successful strategy.
EXPERIMENTAL PROCEDURES
Sample Collection
Colon cancers and paired histologically normal tissues were collected from
patients undergoing surgery at JHU Hospital and Karolinska University
Hospital (see Supplemental Experimental Procedures). These studies were
approved by the Johns Hopkins Institutional Review Board and by the regional
ethical board at the Karolinska Institutet.
Fluorescent In Situ Hybridization Analysis
FISH analysis was carried out as previously described (Dejea et al., 2014) and
is provided in Supplemental Experimental Procedures.
Microbial Culture
Anaerobic tissue specimens collected in specialized transport media
(Anaerobe Systems) were washed twice with 0.016% DTT in saline prior to
hand homogenization in saline under anaerobic conditions. Tissue homoge-
nate was diluted (100–106) and plated on pre-reduced non-selective Brucella
blood agar (Bru) plates. Plates were stored under anaerobic conditions at
37C until colony forming unit counts could be obtained (24–72 hr).
Untargeted Metabolomics
Samples were analyzed by RPLC (reverse-phase liquid chromatography) and
HILIC ESI-QTOFMS (hydrophilic interaction liquid chromatography electro-
spray ionization quadrupole time-of-flight mass spectrometry) as previously
described (Ivanisevic et al., 2013). The full dataset is available as a public share
on XCMS Online. See Supplemental Experimental Procedures.896 Cell Metabolism 21, 891–897, June 2, 2015 ª2015 Elsevier Inc.Targeted Metabolomics of Polyamines
A Scherzo SM-C18 column (Imtakt) effectively retained and separated the
polyamines and polyamine metabolites. Samples were analyzed using an
Agilent Technologies series 1200 HPLC connected to an Agilent Technologies
6410 QqQ-MS as described in Supplemental Experimental Procedures.
NIMS Analysis
NIMS substrates were prepared as previously described (Woo et al., 2008) and
are detailed in the Supplemental Experimental Procedures.
Hematoxylin and Eosin and SSAT Immunohistochemical Staining
Standard protocols were used (see Supplemental Experimental Procedures).
Global Isotope Metabolomics
HT-29 cell lines were dosed with [U-14N]- and [U-15N]-N1, N12-diacetylsper-
mine for 24 hr and extracted in organic solvent for HPLC-ESI-QTOFMS
(high-performance liquid chromatography electrospray ionization quadrupole
time-of-flight mass spectrometry) as for the untargeted metabolomics method
described above. See Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.04.011.
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